Addiction Research
According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.
Addiction Research Products Targets
- Others (13)
- D4 Receptor (12)
- 5-HT7 Receptor (11)
- 5-HT6 Receptor (14)
- 5-ht5 Receptor (2)
- 5-HT4 Receptor (17)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- D3 Receptor (12)
- NMDA Receptor (87)
- Kainate Receptor (22)
- D2 Receptor (14)
- D1 and D5 Receptor (16)
- Glutamate Transporter (18)
- Dopamine Transporter (20)
- CRF2 Receptor (3)
- CRF1 Receptor (5)
- 5-HT Transporter (30)
- Delta opioid receptor (16)
Products for Addiction Research - Page 9
- Cat.No. Product Name Information/Activity
-
BCC7888
EMDT oxalate
EMDT oxalate is a selective 5-HT
-
BCC7919
ST 1936 oxalate
1210-81-7
-
BCC7807
WAY 208466 dihydrochloride
1207064-61-6
-
BCC7650
BGC 20-761
High affinity 5-HT<sub>6</sub> antagonist
-
BCC6127
MS 245 oxalate
275363-58-1
-
BCC7629
NPS ALX Compound 4a dihydrochloride
NPS ALX Compound 4a is a potent and selective 5-hydroxytryptamine6 (5-HT6) receptor antagonist with an IC50 of 7.2 nM, which also has a great binding affinity with Ki of 0.2 nM.
-
BCC7512
Ro 04-6790
202466-68-0
-
BCC7216
SB 258585 hydrochloride
1216468-02-8
-
BCC1924
SB 271046 hydrochloride
SB271046 Hydrochloride is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9.
-
BCC7750
SGS 518 oxalate
445441-27-0


